Norepinephrine-induced blood pressure rise and renal vasoconstriction are not attenuated by enalapril treatment in microalbuminuric IDDM.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  1998-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/NDT/13.3.640PMID 9550640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives

  2004cited by this paper
• Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

  1996cited by this paper
• Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.

  1994cited by this paper
• Enhanced Pressor Responsiveness to Norepinephrine in Type II Diabetes: Effect of ACE inhibition

  1994cited by this paper
• Enalapril blunts the antinatriuretic effect of circulating noradrenaline in man

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

  1993cited by this paper
• Abnormal plasma noradrenaline response and exercise induced albuminuria in type 1 (insulin-dependent) diabetes mellitus.

  1992cited by this paper
• Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure.

  1992cited by this paper
• ACE Inhibition and Pressor Responsiveness to Norepinephrine in Hypertensive Patients

  1990cited by this paper
• Cardiovascular regulation during angiotensin converting enzyme inhibition with captopril in diabetes-associated hypertension.

  1990cited by this paper
• Renal haemodynamic changes in response to moderate hyperglycaemia in type 1 (insulin‐dependent) diabetes mellitus

  1990cited by this paper
• Antihypertensive contribution of sodium depletion and the sympathetic axis during chronic angiotensin II converting enzyme inhibition.

  1988cited by this paper
• Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.

  1988cited by this paper
• Diuretic Effects of Angiotensin‐Converting Enzyme Inhibition: Comparison of Low and Liberal Sodium Diet in Hypertensive Patients

  1987cited by this paper
• Baroreflex control of plasma norepinephrine and heart period in healthy subjects and diabetic patients.

  1986cited by this paper
• Captopril decreases vascular reactivity independently of changes in converting enzyme activity and prostaglandin release in the rat isolated kidney.

  1982cited by this paper
• Evidence for postsynaptic effect of captopril in isolated perfused rabbit kidney.

  1982cited by this paper
• Exaggerated pressor responsiveness to norepinephrine in nonazotemic diabetes mellitus.

  1981cited by this paper
• Attenuation by SQ 14,255 (captopril) of the vascular response to noradrenaline in the rate isolated kidney.

  1980cited by this paper
• Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus.

  1979cited by this paper

• Renal agenesis and unilateral nephrectomy: what are the risks of living with a single kidney?

  2009cites this paper
• ANP but not BNP reflects early left diastolic dysfunction in type 1 diabetics with myocardial dysinnervation.

  2002cites this paper
• The Use of Dopamine and Norepinephrine in the ICU

  1998cites this paper